FLAREX 0.1 %
FLUOROMETHOLONE ACETATE : 0.1 % · DIN 00756784 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is FLAREX?
FLAREX 0.1 % contains FLUOROMETHOLONE ACETATE : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 00756784, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as SUSPENSION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 20-Mar-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FLAREX used for?
FLAREX ® (fluorometholone acetate ophthalmic suspension) is indicated for the treatment of allergic and other steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00756784 |
|---|---|
| Brand name | FLAREX |
| Generic / active ingredient | FLUOROMETHOLONE ACETATE : 0.1 % |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 0.1 % |
| Dosage form | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01BA07 FLUOROMETHOLONE |
| AHFS class | 52:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Mar-2025 |
| Original market date | 1987-12-31 00:00:00 |
How is it stored and handled?
Protect from freezing. Store upright at room temperature. Keep out of the reach and sight of children.
How is it supplied?
5 mL DROP-TAINER dispensers
What can be used instead?
Other Canadian products sharing ATC code S01BA07 FLUOROMETHOLONE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FML | 0.1 % | SUSPENSION | ABBVIE CORPORATION | MARKETED | DIN 00247855 |
| SANDOZ FLUOROMETHOLONE | 0.1 % | SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00432814 |
| FML FORTE SUS 0.25% | 0.25 % | SUSPENSION | ALLERGAN INC | CANCELLED POST MARKET | DIN 00707511 |
| PMS-FLUOROMETHOLONE | 0.1 % | SUSPENSION | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02238568 |
Who else supplies FLUOROMETHOLONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUOROMETHOLONE appears in 18 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.